Bangladesh Seeks Stakeholder Nod Before Banning Six Generics
This article was originally published in PharmAsia News
Executive Summary
Six generic drugs long-banned in other countries remain on sale in Bangladesh as the nation's Drug Control Committee weighs the issue at the beginning of a long process kicked off by a meeting with stakeholders.